Kornitzer Capital Management Inc. KS increased its position in shares of The Clorox Company (NYSE:CLX – Free Report) by 7.6% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 216,411 shares of the company’s stock after purchasing an additional 15,346 shares during the quarter. Kornitzer Capital Management Inc. KS’s holdings in Clorox were worth $17,531,000 as of its most recent filing with the SEC.
Several other hedge funds have also recently added to or reduced their stakes in CLX. NewEdge Advisors LLC increased its holdings in shares of Clorox by 11.8% in the second quarter. NewEdge Advisors LLC now owns 75,135 shares of the company’s stock valued at $7,171,000 after purchasing an additional 7,956 shares during the last quarter. Public Employees Retirement System of Ohio purchased a new position in Clorox during the second quarter worth approximately $3,277,000. Corient Private Wealth LP purchased a new position in Clorox during the second quarter worth approximately $6,621,000. Allen Mooney & Barnes Investment Advisors LLC lifted its position in Clorox by 3,309.3% during the third quarter. Allen Mooney & Barnes Investment Advisors LLC now owns 186,316 shares of the company’s stock worth $15,093,000 after buying an additional 180,851 shares in the last quarter. Finally, Bank of America Corp DE boosted its stake in Clorox by 6.1% during the first quarter. Bank of America Corp DE now owns 1,405,774 shares of the company’s stock worth $145,680,000 after buying an additional 80,618 shares during the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.
Insider Activity at Clorox
In other Clorox news, Director Pierre Breber purchased 4,000 shares of the stock in a transaction dated Wednesday, November 4th. The stock was acquired at an average cost of $100.06 per share, for a total transaction of $400,240.00. Following the acquisition, the director owned 22,000 shares in the company, valued at $2,201,320. This trade represents a 22.22% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.51% of the stock is currently owned by company insiders.
Clorox Stock Up 0.1%
CLX stock opened at $99.80 on Friday. The Clorox Company has a one year low of $79.12 and a one year high of $128.90. The firm has a market cap of $12.09 billion, a PE ratio of 17.95, a PEG ratio of 3.15 and a beta of 0.59. The firm’s 50 day moving average price is $87.71 and its 200-day moving average price is $99.67. The company has a debt-to-equity ratio of 32.91, a quick ratio of 0.38 and a current ratio of 0.65.
Clorox (NYSE:CLX – Get Free Report) last issued its quarterly earnings data on Monday, November 2nd. The company reported $1.55 earnings per share for the quarter, topping the consensus estimate of $1.07 by $0.48. The company had revenue of $1.91 billion during the quarter, compared to analyst estimates of $1.88 billion. Clorox had a return on equity of 608.30% and a net margin of 9.41%. The firm’s revenue for the quarter was up 33.3% compared to the same quarter last year. During the same period in the prior year, the business posted $0.85 earnings per share. On average, equities research analysts anticipate that The Clorox Company will post 5.75 EPS for the current year.
Clorox Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Wednesday, October 28th will be paid a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 5.0%. The ex-dividend date of this dividend is Wednesday, October 28th. Clorox’s dividend payout ratio is 89.93%.
Analyst Upgrades and Downgrades
Several analysts have issued reports on the company. BNP Paribas Exane dropped their target price on Clorox from $97.00 to $95.00 and set a “neutral” rating for the company in a report on Monday, July 20th. UBS Group set a $88.00 price target on Clorox in a report on Tuesday. Morgan Stanley boosted their price target on shares of Clorox from $87.00 to $94.00 and gave the company an “equal weight” rating in a research report on Wednesday. Barclays dropped their price objective on shares of Clorox from $84.00 to $80.00 and set an “underweight” rating for the company in a report on Friday, October 16th. Finally, Wall Street Zen upgraded shares of Clorox from a “sell” rating to a “hold” rating in a research report on Saturday. One investment analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and four have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Clorox has a consensus rating of “Reduce” and an average target price of $93.79.
Read Our Latest Stock Report on CLX
Clorox Company Profile
The Clorox Company is a consumer products company founded in 1913 and headquartered in Oakland, California. It makes and markets products for household cleaning, food, water filtration, personal care and pet care.
Its portfolio includes Clorox disinfecting and cleaning products, Glad trash bags and food-storage products, Kingsford charcoal, Brita water filters, Hidden Valley dressings and sauces, Burt’s Bees personal-care products, and Fresh Step cat litter. The company also sells products under brands such as Pine-Sol and Liquid-Plumr.
Clorox serves consumers primarily in the United States and also sells products in international markets.
Featured Stories
- Five stocks we like better than Clorox
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
